A new option for adults who have experienced stroke will now be available to further reduce future risk.
News|Articles|February 6, 2006
Consumers work out aches and pains with new OTCs
Consumers who are sticking to their New Year's resolution to get in shape may be looking for products to ease the aches and pains that come with working out. What new OTCs will these exercise buffs find on pharmacy shelves to treat their discomfort?
Advertisement
Advertisement
Related to this article
Findings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.
Gilead’s current lenacapavir patent is what makes Dr Reddy’s Laboratories’ formulation tentative.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Adds NAION Eye Risk Warning to All GLP-1 Labels
2
Vaxcyte’s VAX-31 Pneumococcal Vaccine Meets All Phase 3 Primary Goals
3
New Report Finds Pharmacies Key in Long-Term GLP-1 Success
4
COVID-19 Vaccines Paid Off Up to $809 Per Dollar Spent in 2021
5